Option chain shows key data for Windtree Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Windtree Therapeutics.

Windtree Therapeutics (NASDAQ:WINT) Stock, Option Chain

Windtree Therapeutics

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.

nyse shutter

Analyst Color

Earnings

Equities

Government

News

Regulations

Bonds

Guidance

Commodities

Treasuries

Economics

Federal Reserve

Pre-Market Outlook

Markets

Analyst Ratings

ETFs

General

$BTC

CISO

HUMA

SURG

THTX

WINT

U.S. stock futures were trading lower on Wednesday, after advancing for three consecutive sessions. Futures of major benchmark indices were lower in premarket trading.

US Stocks Likely To Open Lower After 3-Day Advance: Market Is Looking &#39;More Balanced&#39; And Gone From &#39;Above-Trend To On-Trend,&#39; Says Expert

GameStop Corp.

Movers

Trading Ideas

BHIL

BSGM

CLEU

GDHG

IMTE

NYXH

ORKA

PTPI

RAPP

TXMD

ZYBT

Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

doctor-2568481

Windtree Therapeutics shares are trading higher by 37% during Monday&#39;s session. The company regained compliance with Nasdaq&#39;s minimum bid price requirement, ensuring its continued listing.

What&#39;s Going On With Windtree Therapeutics (WINT) Stock?

Windtree Therapeutics, Inc. - Common Stock

Windtree Therapeutics Inc

Windtree Therapeutics Inc arrants (25/03/2026)

WINTO GROUP HLDGS LTD by WINTO GROUP HLDGS LTD.

Wintrust Financial Corporation - Common Stock

Wintrust Financial Corp

Wintrust Financial Corporation - Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series D

Wintrust Financial Corporation - Depositary Shares, Each Representing a 1/1,000th Interest in a Share of 6.875% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series E

Legal

Press Releases

Windtree Strengthens Global Intellectual Property Portfolio with New Japanese Patent For the Company's Oncology Pipeline

Windtree Announces Special Late-Breaking Clinical Science Abstract Presentation on Istaroxime at the Technology and Heart Failure Therapeutics Conference

Windtree Therapeutics, Inc. Announces Reverse Stock Split

Health Care

Windtree Files Istaroxime Cardiogenic Shock and Prevention of Arrythmias Patent for India

Windtree Announces Istaroxime Notice of Allowance from the U.S. Patent and Trademark Office for Acute Heart Failure

Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product

Windtree Therapeutics Regains Compliance with Nasdaq Listing Rules

Small Cap

Evofem Reports Fourth Consecutive Year of Net Sales Growth

Health In Tech (Nasdaq: HIT) Surges Into 2025 With 50% Revenue Growth and Game-Changing AI Healthcare Solutions – More Stocks Inside

Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics

ADTX

DYAI

EVFM

KAVL

MLGO

XHLD

Apollomics

Aptevo Therapeutics

Bone Biologics

Biodexa Pharmaceuticals plc - American Depositary Shares

Biodexa Pharmaceuticals

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Pasithea Therapeutics Corp. - Common Stock

Pasithea Therapeutics

Onconetix

Palisade Bio

Polyrizon

Protagenic Therapeutics, Inc. - Common Stock

Protagenic Therapeutics

TransCode Therapeutics, Inc. - Common Stock

TransCode Therapeutics

Scorpius Holdings

Salarius Pharmaceuticals, Inc. - Common Stock

Salarius Pharmaceuticals

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Vincerx Pharma

ZyVersa Therapeutics, Inc. - Common Stock

ZyVersa Therapeutics

HC Wainwright & Co.

Screenshot 2024-10-07 at 6.29.09 PM

Biotech

Windtree Therapeutics (NASDAQ: WINT) Announces Positive Phase 2b Results For Istaroxime In Early Cardiogenic Shock Treatment

Comments

Windtree Therapeutics

Windtree Therapeutics (WINT) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga